Compare CURI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURI | CBUS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | 45 | N/A |
| Industry | Movies/Entertainment | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.6M | 208.7M |
| IPO Year | N/A | 2017 |
| Metric | CURI | CBUS |
|---|---|---|
| Price | $3.34 | $3.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $5.83 | ★ $20.00 |
| AVG Volume (30 Days) | 376.4K | ★ 548.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 10.00% | N/A |
| EPS Growth | N/A | ★ 58.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,262,000.00 |
| Revenue This Year | $9.52 | N/A |
| Revenue Next Year | $16.90 | $99.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 134.56 |
| 52 Week Low | $2.30 | $1.09 |
| 52 Week High | $7.15 | $4.19 |
| Indicator | CURI | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 62.16 |
| Support Level | $3.07 | $1.34 |
| Resistance Level | $4.96 | N/A |
| Average True Range (ATR) | 0.19 | 0.31 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 40.96 | 60.32 |
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.